114 M.E. Abood
Singh R, Hurst DP, Barnett-Norris J, Lynch DL, Reggio PH, Guarnieri F (2002) Activation of
the cannabinoid CB1 receptor may involve a W6 48/F3 36 rotamer toggle switch. J Pept
Res 60:357–370
Soderstrom K, Leid M, Moore FL, Murray TF (2000a) Behavioral, pharmacological, and
molecular characterization of an amphibian cannabinoid receptor.JNeurochem75:413–
423
Soderstrom K, Leid M, Moore FL, Murray TF (2000b) Behavioral, pharmacological, and
molecular characterization of an amphibian cannabinoid receptor.JNeurochem75:413–
423
Song Z, Slowey C-A, Hurst D, Reggio P (1999) The difference between the CB1 and CB2
cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for
CB2. Mol Pharmacol 56:834–840
Song Z-H, Bonner TI (1996) A lysine residue of the cannabinoid receptor is critical for re-
ceptor recognition by several agonists but not WIN55212-2. Mol Pharmacol 49:891–896
SongZH,FengW(2002)Absenceofaconservedprolineandpresenceofaconservedtyrosine
in the CB2 cannabinoid receptor are crucial for its function. FEBS Lett 531:290–294
SteinerH,BonnerT,ZimmerA,KitaS,ZimmerA(1998)CB1cannabinoidreceptorknockout
mice display increased neuropeptide expression in striatal output pathways and are
hypoactive in an exploratory test. Soc Neurosci 24:411
Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates
long-term potentiation. Nature 388:773–778
Sugiura T, Kodaka T, Kondo S, Nakane S, Kondo H, Waku K, Ishima Y, Watanabe K,
Yamamoto I (1997) Is the Cannabinoid CB1 receptor a 2-arachidonylglycerol receptor?
Structural requirements for Triggering a Ca2+ transient in NG108–15 cells. J Biochem
(Tokyo) 122:890–895
Surprenant A, Horstman DA, Akbarali H, Limbird LE (1992) A point mutation of the alpha
2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science
257:977–980
Tanda G, Pontieri F, Chiara GD (1997) Cannabinoid and heroin activation of mesolim-
bic dopamine transmission by a common mu1 opioid receptor mechanism. Science
276:2048–2050
Tao Q, Abood ME (1998) Mutation of a highly conserved aspartate residue in the second
transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein
coupling. J Pharmacol Exp Ther 285:651–658
TaoQ,McAllisterS,AndreassiJ,NowellK,CabralG,HurstD,BachtelK,EkmanM,Reggio
P, Abood M (1999) Role of a conserved lysine residue in the peripheral cannabinoid
receptor (CB2): evidence for subtype specificity. Mol Pharmacol 55:605–613
Thomas W, Qian H, Chang C, Karnik S (2000) Agonist-induced phosphorylation of the
angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct
from the inositol phosphate-signaling state. J Biol Chem 275:2893–2900
ValkPJM,HolS,VankanY,IhleJN,AskewD,JenkinsNA,GilbertDJ,CopelandNG,deBoth
NJ, Lowenberg B, Delwel R (1997) The genes encoding the peripheral cannabinoid re-
ceptor andα-L-fucosidase are located near a newly identified common virus integration
site. J Virol 71:6796–6804
Vasquez C, Lewis D (1999) The CB1 cannabinoid receptor can sequester G-proteins, making
them unavailable to couple to other receptors. J Neurosci 19:9271–9280
Venance L, Piomelli D, Glowinski J, Giaume C (1995) Inhibition by anandamide of gap
junctions and intercellular calcium signalling in striatal astrocytes. Nature 376:590–594
Wagner J, Varga K, Jarai Z, Kunos G (1999) Mesenteric vasodilation mediated by endothelial
anandamide receptors. Hypertension 33:429–434
Walker J, Huang S, Strangman N, Tsou K, Sanudo-Pena M (1999) Pain modulation by release
of the endogenous cannabinoid anandamide. Proc Natl Acad Sci USA 96:12198–12203
Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N (2003)
Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci
23:1398–1405